Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-005027
Filing Date
2012-05-15
Accepted
2012-05-15 06:02:54
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q talon_10q-033112.htm 10-Q 948233
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10803
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10547
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4556
  Complete submission text file 0001437749-12-005027.txt   4148534

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE tlonob-20120331.xml EX-101.INS 747300
6 XBRL TAXONOMY EXTENSION SCHEMA tlonob-20120331.xsd EX-101.SCH 25664
7 XBRL TAXONOMY EXTENSION CALCULATION tlonob-20120331_cal.xml EX-101.CAL 21514
8 XBRL TAXONOMY EXTENSION DEFINITION tlonob-20120331_def.xml EX-101.DEF 109079
9 XBRL TAXONOMY EXTENSION LABELS tlonob-20120331_lab.xml EX-101.LAB 146379
10 XBRL TAXONOMY EXTENSION PRESENTATION tlonob-20120331_pre.xml EX-101.PRE 111741
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32626 | Film No.: 12840838
SIC: 2834 Pharmaceutical Preparations